In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmo Pharmaceuticals N.V.

https://www.cosmopharma.com/

Latest From Cosmo Pharmaceuticals N.V.

Finance Watch: CARB-X Refills Coffers To Help Biopharmas Fight Resistant Bacteria

Private Company Edition: The global accelerator has new commitments from HHS and the Wellcome Trust. Also, Apollo buys into Sofinnova Partners with an up to €1bn investment, Castle Creek raised $124.6m in private funding this year in lieu of an IPO and Remix closed a $70m series B round. 

Financing Innovation

Deal Watch: How Did J.P. Morgan Deal-Making Compare To Prior Years?

Licensing deals and partnerships carried the day during another hectic J.P. Morgan Healthcare Conference. Pfizer racked up its third deal of the week in a cancer collaboration with Dren Bio.

Deal Watch Business Strategies

Digital Health Roundup, April 2021: Digital Transformation In OR, Clinical Trials, Remote Monitoring

In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from April.

Digital Health Artificial Intelligence

FDA Authorizes GI Genius As A Smarter AI-Based Colonoscopy Tool

According to a large clinical study, the first such device with AI-enabled software is better at detecting potential lesions than traditional colonoscopies and could allow detection of colon cancer sooner.

Research & Development Regulation
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Other Names / Subsidiaries
    • Aries Group, Ltd
    • Aries Pharmaceuticals, Inc.
    • BioXell
    • Cosmo Technologies Limited
    • Cosmo Pharmaceuticals S.p.A.
UsernamePublicRestriction

Register